Skip to main content
. Author manuscript; available in PMC: 2017 May 2.
Published in final edited form as: Microvasc Res. 2012 May 25;84(2):161–168. doi: 10.1016/j.mvr.2012.05.003

Table 2.

Real-time PCR (qPCR) Data

Treatment 50 μg/ml AGP 500 μg/ml AGP
Target Gene 3 hrs 6 hrs 12 hrs 24 hrs 48 hrs 3 hrs 6 hrs 12 hrs 24 hrs 48 hrs
Cytokines
IL-10 1.17 ± 0.1 1.34 ± 0.3 0.72 ± 0.1 1.03 ± 0.2 0.97 ± 0.0 0.47 ± 0.0 1.68 § ± 0.0 1.89 ± 0.2 1.02 ± 0.1 0.49 * ± 0.1
TNF-α 0.25 ± 0.1 1.99 ± 0.1 1.22 ± 0.2 0.74 ± 0.1 1.18 ± 0.3 0.40 ± 0.0 1.71 § ± 0.1 1.69 § ± 0.1 0.97 ± 0.3 0.97 ± 0.0
IL-1β 0.84 ± 0.1 3.42 § ± 1.1 0.93 ± 0.1 0.29 ± 0.1 2.02 ± 0.6 2.27 ±0.9 1.81 ± 0.7 12.36 ± 0.4 4.55 ± 0.3 1.46 ± 0.2
IL-6 0.96 ± 0.0 2.46 ± 0.1 3.06 ± 0.1 2.45 ± 0.5 2.63 ± 0.4 1.49 ±0.6 30.45 ± 4.4 8.56 § ± 1.0 26.32 ± 2.9 20.09 § ± 3.7
TJ Proteins
Occludin 1.43 ± 0.4 0.90 ± 0.0 1.60 § ± 0.2 1.01 ± 0.2 0.64 ± 0.2 0.66 ± 0.1 0.82 ± 0.1 0.58 * ± 0.1 0.47 ± 0.2 0.36 ± 0.1
ZO-1 2.19* ±0.7 0.66 * ± 0.1 1.22 ± 0.1 0.75 ± 0.2 0.73 ± 0.1 3.4 § ± 0.9 0.97 ± 0.1 0.90 ± 0.2 0.38 ± 0.1 0.39 ± 0.1
Claudin-2 1.45 ± 0.1 0.48 ± 0.2 1.08 ± 0.1 0.24 ± 0.1 0.29 ± 0.0 0.73 ± 0.0 0.76 ± 0.1 1.09 ± 0.0 0.48 ± 0.0 0.22 ± 0.0
Claudin-5 1.20 ± 0.1 1.01 ± 0.1 1.34 ± 0.4 1.89 ± 0.4 5.87 ± 0.7 0.54 ± 0.1 1.36 ± 0.1 0.54 * ± 0.1 0.85 ± 0.2 2.42 § ± 0.3
JAM-1 1.08 ± 0.2 0.64 ± 0.1 1.60 ± 0.2 0.28 ± 0.1 0.38 § ± 0.2 0.65 ± 0.3 0.45 § ± 0.1 1.44 * ± 0.2 0.47 § ± 0.1 0.32 ± 0.1

Results have been calculated using the Pfaffl method to produce a ratio (treatment: control) that represents mean ± SEM for the effect of the treatment on mRNA expression for the respective target gene with GAPDH as the reference gene.

*

indicates p-value <0.05;

§

indicates p-value <0.01;

indicates p-value <0.001, compared with respective control; ratio means larger than two or less than 0.5 are bolded; n= 3–6.